# Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study

> **NCT02211482** · PHASE4 · COMPLETED · sponsor: **Fundación Huésped** · enrollment: 20 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** dolutegravir, lamivudine

## Key facts

- **NCT ID:** NCT02211482
- **Lead sponsor:** Fundación Huésped
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-03
- **Final completion:** 2017-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211482, "Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02211482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*